Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2021

Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition

Résumé

Since the advent of highly effective combined antiretroviral treatment (cART), and with the implementation of large HIV testing programs and universal access to cART, the burden of AIDS-related comorbidities has dramatically decreased over time. The incidence of Kaposi’s sarcoma (SK), strongly associated with HIV replication and CD4 immunosuppression, was greatly reduced. However, KS remains the most common cancer in patients living with HIV (PLHIV). HIV physicians are increasingly faced with KS in virally suppressed HIV-patients, as reflected by increasing description of case series. Though SK seem less aggressive than those in PLHIV with uncontrolled HIV-disease, some may require systemic chemotherapy. Persistent lack of specific anti-HHV-8 cellular immunity could be involved in the physiopathology of these KS. These clinical forms are a real therapeutic challenge without possible short-term improvement of anti-HHV-8 immunity, and no active replication of HIV to control. The cumulative toxicity of chemotherapies repeatedly leads to a therapeutic dead end. The introduction or maintenance of protease inhibitors in cART does not seem to have an impact on the evolution of these KS. Research programs in this emerging condition are important to consider new strategies
Fichier principal
Vignette du fichier
cancers-13-05702(1).pdf (310.61 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03456567 , version 1 (30-11-2021)

Identifiants

Citer

Romain Palich, Alain Makinson, Marianne Veyri, Amélie Guihot, Marc-Antoine Valantin, et al.. Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition. Cancers, 2021, 13 (22), pp.5702. ⟨10.3390/cancers13225702⟩. ⟨hal-03456567⟩
58 Consultations
100 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More